IHC.L's capital structure is characterized by a debt-to-equity ratio of 0.9, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current…
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 1.37, indicating a significant reliance on debt financing. Despite a positive operating cash flow of 7.28 million…
Initiator Pharma A/S maintains a strong liquidity position, with a current ratio of 15.4, indicating that its current assets significantly exceed its current liabilities. The company holds DKK 14.4…
IRIDEX Corp's capital structure shows a liquidity position of $6.03 million in cash and equivalents, with a current ratio of 1.91, indicating moderate short-term liquidity. The company's price-to-b…
Jasper Therapeutics has a highly liquid capital structure, with $118.48 million in cash and equivalents and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The company's current rati…
Joint Corp maintains a strong liquidity position, with $17.46 million in cash and equivalents, representing 21.2% of total assets. The company's price-to-book ratio of 5.05 suggests a premium valua…
Kairos Pharma operates with a negative net equity of $2.65 million and a total liabilities of $3.68 million, indicating a highly leveraged and capital-intensive structure. The company's liquidity p…
KPJ Healthcare Bhd maintains a debt-to-equity ratio of 1.44, indicating a moderate reliance on debt financing, and a current ratio of 1.52, suggesting adequate short-term liquidity to cover its obl…
Kazia Therapeutics operates with a negative equity position of -8.3 million AUD and a debt-to-equity ratio of -0.43, indicating a capital structure that is heavily leveraged and reliant on external…
LeonaBio maintains a strong liquidity position, with a current ratio of 3.97 and cash and equivalents of $73.8 million, which significantly exceeds its total liabilities of $27.9 million. The compa…
908 Devices Inc maintains a strong liquidity position with $70.5 million in cash and equivalents, representing 37.1% of total assets, and a current ratio of 4.24, well above the median for its indu…
MKDWELL Tech Inc has a current ratio of 3.66, indicating strong short-term liquidity, but its operating cash flow of -73.35 million USD and free cash flow of -91.71 million USD suggest significant…
MediciNova Inc has a strong liquidity position, with a current ratio of 8.16 and cash and equivalents amounting to $30.8 million, which significantly exceeds its total liabilities of $4.02 million.…
Satellos Bioscience Inc has a liquidity position characterized by a current ratio of 7.77, indicating strong short-term liquidity, and no long-term debt, which suggests a conservative capital struc…
Navamedic ASA maintains a capital structure characterized by zero debt, with a debt-to-equity ratio of 0.0. The balance sheet shows total assets of 512.3 million NOK against total liabilities of 33…
Navamedic's capital structure shows a debt-to-equity ratio of 0.62, indicating a moderate reliance on debt financing. The company holds 72.57 million NOK in cash and equivalents, but with long-term…
NKT.BK's capital structure is characterized by a low debt-to-equity ratio of 0.04, indicating a conservative leverage position relative to its equity base. The company's liquidity is assessed as me…
NN6G.DE exhibits a strong liquidity position, with a current ratio of 49.94, indicating a substantial ability to cover short-term liabilities with current assets. The company holds EUR 9,098,120 in…
Nutriband Inc operates with a capital structure that is highly liquid, as evidenced by $4.57 million in cash and equivalents, which significantly exceeds its total liabilities of $0.87 million. The…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.13, indicating a conservative leverage position. However, the free cash flow is negative at -12.43 million GBP, w…
Pango operates with a current liquidity position that is moderate, as indicated by a current ratio of 1.87, which is below the typical threshold of 2 for strong liquidity. The company's liquidity i…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.11, indicating a conservative leverage position. However, the liquidity risk is assessed as low, and the current…
Philogen maintains a strong capital structure with a debt-to-equity ratio of 0.03, indicating minimal leverage and a conservative financing approach. The company's liquidity position is characteriz…
PIHLIS.HE has a liquidity ratio of 0.73, indicating that its current assets are less than its current liabilities, which suggests a potential liquidity risk. The company's debt-to-equity ratio is 1…
Polynovo operates with a capital structure that includes a total equity of AUD 83.26 million and total liabilities of AUD 44.15 million, resulting in a debt-to-equity ratio of 0.21. The company's l…
Prenetics operates with a strong equity base, as reflected in its total equity of $174.6 million, and a low debt-to-equity ratio of 0.01, indicating a conservative capital structure. The company's…
Physitrack operates with a capital structure that includes total liabilities of EUR 13.28 million and total equity of EUR 25.29 million, resulting in a debt-to-equity ratio of 0.17. The company mai…
Q linea AB has a market price of 18.2 SEK and a market capitalization of 344,867,286.4 SEK. The company's price-to-book ratio is 5.06, and its price-to-tangible-book ratio is also 5.06. The enterpr…
Quantum-Si operates with a strong liquidity position, as evidenced by a current ratio of 7.64 and $21.64 million in cash and equivalents, despite a negative operating cash flow of -$94.72 million.…
RHC.AX has a debt-to-equity ratio of 2.41, indicating a significant reliance on debt financing, which is higher than the typical industry median for healthcare facilities and services. The company'…
SCYNEXIS Inc operates with a market capitalization of $61.23 million and a price-to-book ratio of 1.01, indicating a valuation that closely aligns with its book value. The company holds $25.99 mill…
Solventum Corp maintains a liquidity position with a current ratio of 1.23, indicating a moderate ability to meet short-term obligations. The company's price-to-book ratio is 2.64, suggesting that…
The company's capital structure is highly leveraged, with total liabilities of $80.29 million and total equity of -$15.08 million, resulting in a negative debt-to-equity ratio of -2.0. Liquidity is…
Thyrocare Technologies Ltd has a capital structure with 159.17 million shares outstanding, both basic and diluted, indicating no immediate dilution pressure from share-based compensation or convert…
T Man Pharmaceutical PCL maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.45, indicating a moderate reliance on debt financing. The company's liquidity positi…
Tempest Therapeutics maintains a strong liquidity position, with $32.33 million in cash and equivalents, significantly exceeding its total liabilities of $23.75 million, resulting in a current rati…
Tevogen Bio Holdings Inc operates with a negative equity position of -$7.63 million and a total asset base of $3.31 million, indicating a highly leveraged capital structure. The company's liquidity…
Universal Health Services Inc maintains a debt-to-equity ratio of 0.7, indicating a relatively balanced capital structure with moderate leverage. The company’s liquidity position is characterized a…
The company's capital structure is characterized by a debt-to-equity ratio of 1.28, indicating a relatively high level of leverage. Despite having cash and equivalents of 16,823,000 EUR, the compan…
Vicore Pharma operates with a capital structure that is entirely equity-funded, as evidenced by a debt-to-equity ratio of 0.0 and no long-term debt. The company maintains a strong liquidity positio…
Vyne Therapeutics operates with a strong liquidity position, as evidenced by its cash and equivalents of $24.03 million, which significantly exceeds its total liabilities of $2.395 million, resulti…
Teyi Pharmaceutical Group Co Ltd has a market capitalization of 4.49 billion CNY and a price-to-earnings ratio of 54.99, which is significantly higher than the industry median, indicating a premium…
HLB Inc's capital structure is characterized by a debt-to-equity ratio of 0.21, indicating a relatively conservative leverage position. The company holds 69.49 billion KRW in cash and equivalents,…
Structure and Liquidity Bio Plus Co Ltd has a debt-to-equity ratio of 0.34, indicating a relatively conservative capital structure. However, the company's liquidity position is assessed as medium,…
China Shineway Pharmaceutical Group Ltd maintains a strong liquidity position, as evidenced by a current ratio of 3.71, indicating the company can cover its short-term liabilities more than three t…
The company maintains a strong liquidity position, with a current ratio of 1.77 and a price-to-book ratio of 2.0, indicating a moderate level of leverage and a market valuation that is in line with…
GC Genome Corp has a market capitalization of 161.8 billion KRW, with a market price of 6,840 KRW per share. The company reported a revenue of 5.75 billion KRW in the latest period, but it remains…
The company's capital structure is characterized by a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
The company's capital structure is characterized by a high proportion of equity, with total equity of TWD 742,093,000 and total liabilities of TWD 73,285,000, resulting in a debt-to-equity ratio of…
Japan Hospice Holdings Inc has a market price of 639 JPY per share, with a market capitalization of 5,399,939,790 JPY. The company's price-to-earnings ratio is 35.52, and its price-to-book ratio is…
Abeona Therapeutics Inc maintains a strong liquidity position, with a current ratio of 6.93 and cash and equivalents of $78.44 million, which significantly exceeds its short-term obligations. The c…
ABS.PA operates with a capital structure showing significant leverage, as total liabilities of €46.93 billion exceed total assets of €23.18 billion, resulting in negative equity of €23.75 billion.…
ALERS.PA maintains a conservative capital structure with a debt-to-equity ratio of 0.04, indicating minimal leverage and a strong equity base of EUR 183.9 million. The company's liquidity position…
AOTI.L has a liquidity profile that is characterized by a current ratio of 3.11, indicating a strong ability to meet short-term obligations with its current assets. However, the company's cash and…
Structure and Liquidity BioCardia has a negative net equity position of $1.96 million, indicating a significant deficit in its capital structure. The company's cash and equivalents amount to $1.42…
Black Diamond Therapeutics maintains a strong liquidity position, with a current ratio of 8.42 and $20.99 million in cash and equivalents, indicating a robust ability to meet short-term obligations…
BIO.AX has a market capitalization of AUD 56.54 million and a price-to-earnings ratio of 263.41, indicating a high valuation relative to its earnings. The company's price-to-book ratio is 12.09, su…
BIOPOR.CO's capital structure is characterized by a low debt-to-equity ratio of 0.12, indicating a conservative leverage profile. The company holds substantial cash and equivalents of 54,893,000 DK…
Cryo-Cell operates with a negative equity position of $10.74 million and a debt-to-equity ratio of -0.79, indicating a capital structure heavily reliant on debt financing. The company maintains $46…
Cognition Therapeutics maintains a strong liquidity position, with $36.81 million in cash and equivalents, representing 76% of total assets. The company has no long-term debt and a current ratio of…
Cinclus Pharma operates with a capital structure that includes a low debt-to-equity ratio of 0.02, indicating a conservative leverage position. The company's liquidity is assessed as medium, with a…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.1, indicating a conservative leverage position. However, the liquidity risk is assessed as low, and the current r…
Cue Biopharma Inc has a strong liquidity position, with $27.14 million in cash and equivalents, representing 64.3% of its total assets of $42.21 million. The company has no long-term debt and a deb…
Dental Corporation PCL maintains a debt-to-equity ratio of 0.59, indicating a moderate level of leverage, and a current ratio of 1.37, suggesting adequate short-term liquidity to cover its obligati…
The company maintains a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing, and a current ratio of 2.6, suggesting strong short-term liquidity. However, the risk assessm…
Edap Tms SA has a market price of $4.13 and a market capitalization of $154.8 million, with a price-to-book ratio of 7.97 and a price-to-tangible-book ratio of 7.97. The company's liquidity positio…
The company's capital structure is characterized by a debt-to-equity ratio of 0.38, indicating a relatively conservative leverage position. However, the company is experiencing negative liquidity,…
Genelux Corp operates with a market capitalization of $136.31 million and a price-to-book ratio of 3.62, indicating a premium valuation relative to its book value. The company has no long-term debt…
Genprex operates with a capital structure that is entirely equity-funded, as evidenced by a debt-to-equity ratio of 0.0 and no long-term debt. The company's liquidity position is characterized by a…
GSK plc maintains a capital structure characterized by significant leverage, with long-term debt of £17.72 billion against total equity of £16.38 billion, resulting in a debt-to-equity ratio of 1.0…
HIMS.K has a market price of $26.70, resulting in a market capitalization of $6.17 billion. The company's price-to-earnings ratio is 48.06, and its price-to-book ratio is 11.41, indicating a premiu…
Hansa Biopharma operates with a capital structure that is highly leveraged and liquidity-constrained. The company reported negative equity of -88.99 million SEK and a debt-to-equity ratio of -10.55…
HVO.L's capital structure shows a debt-to-equity ratio of 0.39, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.63,…
IBRX.O has a market capitalization of $8.2 billion and a negative net income of $351.4 million, indicating a significant financial loss. The company's liquidity position is characterized by a curre…
SeaStar Medical Holding Corp operates with a negative equity position of -$4.47 million and a debt-to-equity ratio of -0.91, indicating a leveraged capital structure with liabilities exceeding asse…
Immunovia's capital structure is characterized by a low debt-to-equity ratio of 0.2, indicating a conservative leverage profile. The company holds substantial cash and equivalents of 51.18 million…
Immunic Inc maintains a strong liquidity position, with cash and equivalents amounting to $79.698 million, representing 92.0% of total assets. The company has no long-term debt, and its debt-to-equ…
Implantica AG has a highly liquid capital structure, with a current ratio of 17.81, indicating strong short-term liquidity. However, the company has negative free cash flow of -18.36 million EUR an…
Kilitch Drugs maintains a conservative capital structure with a debt-to-equity ratio of 0.18, indicating limited leverage and a strong equity base. The company holds INR 189.6 million in cash and e…
LACM.KL maintains a relatively strong liquidity position, with a current ratio of 2.11, indicating the company can cover its short-term liabilities with its short-term assets. However, the company…
Lifeward Ltd's capital structure is characterized by a debt-to-equity ratio of 0.33, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a cu…
Lipocine Inc operates with a strong liquidity position, as evidenced by a current ratio of 6.68 and cash and equivalents of $5.21 million. The company has no long-term debt, and its debt-to-equity…
Magle Chemoswed Holding AB has a market price of 3.56 SEK, with a market capitalization of 105,016,831.6 SEK, and a price-to-book ratio of 0.27, indicating a significant discount to its book value.…
Maia Biotechnology Inc has a negative equity position of -$5.76 million and a market cap of $82.51 million, indicating a high degree of financial leverage and a speculative valuation. The company's…
Moberg Pharma maintains a strong liquidity position, with cash and equivalents amounting to 230.95 million SEK, representing a significant portion of its total assets of 682.26 million SEK. The com…
Moleculin Biotech Inc operates with a market capitalization of $11.74 million and a price-to-book ratio of 0.66, indicating a significant discount to its book value. The company holds $10.85 millio…
MDG.WA's capital structure is characterized by a debt-to-equity ratio of 0.1, indicating a relatively low level of leverage. The company's liquidity position is assessed as medium, with a current r…
Neuraxis Inc has a negative equity position of -$3.18 billion and a debt-to-equity ratio of -0.44, indicating a capital structure heavily reliant on debt financing. The company's liquidity position…
Natera operates with a strong liquidity position, as evidenced by $813.8 million in cash and equivalents, which is significantly higher than its total liabilities of $674.1 million, resulting in a…
Envista's capital structure is characterized by a debt-to-equity ratio of 0.47, indicating a relatively conservative leverage position. The company maintains a strong liquidity position with $1.21…
Newron Pharmaceuticals has a negative equity position of EUR -11.14 million, indicating a significant financial leverage burden. The company's liquidity position is characterized by a current ratio…
Outset Medical operates with a market capitalization of $70.6 million and a price-to-book ratio of 0.56, indicating a discount to its tangible asset base. The company holds $35.0 million in cash an…
OPKO Health Inc has a liquidity position that appears stable, with a current ratio of 3.97, indicating the company can cover its short-term liabilities more than three times over. However, the comp…
Outlook Therapeutics has a highly leveraged capital structure, with total liabilities of $50.8 million and total equity of -$32.2 million, indicating a negative net worth. The company's liquidity p…
PharmaCorp Rx Inc maintains a strong liquidity position, with CAD 25.89 million in cash and equivalents, representing a significant portion of its total assets. The company's debt-to-equity ratio o…
Poolbeg Pharma has a market capitalization of £3.9 billion, with a current market price of £5.6 per share, based on 697.2 million shares outstanding. The company's liquidity risk could not be asses…
Praram 9 Hospital PCL maintains a strong liquidity position, with a current ratio of 3.71 and cash and equivalents amounting to 962.05 million THB, indicating a solid ability to meet short-term obl…
Pyxis Oncology Inc has a market capitalization of $142.05 million and a price-to-book ratio of 2.66, indicating that the market values the company at a premium to its book value. The company's liqu…
QT Imaging operates with a market capitalization of $84.3 million and a price-to-book ratio of 13.08, indicating a premium valuation relative to its equity base. The company's liquidity position is…
Raffles Medical Group Ltd maintains a strong liquidity position, with a current ratio of 1.31 and cash and equivalents amounting to SGD 272.28 million, which supports its short-term obligations. Th…
RNTL.DH maintains a debt-to-equity ratio of 0.52, indicating a moderate reliance on debt financing, and a current ratio of 1.37, suggesting adequate short-term liquidity to cover its obligations. H…
Rapid Micro Biosystems has a market capitalization of $117.16 million and a price-to-book ratio of 3.53, indicating that the market is valuing the company at a premium to its book value. The compan…
Rubicon Research Ltd maintains a debt-to-equity ratio of 0.77, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with…
SIGA Technologies Inc maintains a strong liquidity position, with $143.9 million in cash and equivalents and no long-term debt, resulting in a debt-to-equity ratio of 0.0 and a current ratio of 3.0…
Neuronetics operates with a high debt-to-equity ratio of 3.08, indicating a capital structure heavily reliant on debt financing. The company holds $42.64 million in cash and equivalents, but this i…
Syngene International Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.09, indicating a low reliance on debt financing. The company's liquidity position is characteri…
TruBridge operates with a debt-to-equity ratio of 1.0, indicating a balanced capital structure, while its current ratio of 1.95 suggests moderate liquidity. The company's price-to-book ratio of 2.1…
TriSalus Life Sciences Inc has a negative net equity of -$33.86 million, indicating a significant financial leverage position, with total liabilities exceeding total assets by $33.86 million. The c…
Tonix Pharmaceuticals has a strong liquidity position, with $207.6 million in cash and equivalents and no long-term debt, resulting in a debt-to-equity ratio of 0.0 and a current ratio of 7.42. How…
Top Glove Corporation Bhd maintains a conservative capital structure, with a debt-to-equity ratio of 0.18, indicating a relatively low reliance on debt financing. The company's liquidity position i…
VHI.TO maintains a strong liquidity position, with a current ratio of 2.4 and cash and equivalents amounting to CAD 57.63 million, which supports its short-term obligations. The company's debt-to-e…
Zota Health Care Ltd has a debt-to-equity ratio of 0.62 and a current ratio of 1.83, indicating moderate leverage and sufficient short-term liquidity to cover its obligations. However, the company'…
The company maintains a strong liquidity position, with a current ratio of 6.58, indicating a high ability to meet short-term obligations. Free cash flow stands at 458.84 million CNY, while operati…
The company maintains a relatively strong liquidity position, with a current ratio of 2.37, indicating that it has more than twice the current assets to cover its current liabilities. However, its…
Grand Pharmaceutical Group Ltd maintains a relatively strong liquidity position, with a current ratio of 1.14, indicating that its current assets slightly exceed its current liabilities. However, t…
Seegene Inc maintains a strong liquidity position, with a current ratio of 4.68 and cash and equivalents amounting to KRW 225.57 billion, indicating a robust ability to meet short-term obligations.…
Ascletis Pharma Inc operates with a highly leveraged capital structure, as evidenced by a price-to-book ratio of 8.04 and a price-to-tangible-book ratio of 8.04, indicating that the market is valui…
Structure and Liquidity Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC has a debt-to-equity ratio of 1.01, indicating a balanced capital structure with debt and e…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥6.84 billion, significantly exceeding its total liabilities of ¥481 million. The liquidity FPT (free cash…
The company maintains a strong liquidity position, with a current ratio of 17.06, indicating a high ability to meet short-term obligations. Its cash and equivalents amount to 10,754,466,080 KRW, wh…
L&C Bio Co Ltd has a capital structure marked by a debt-to-equity ratio of 0.47, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a cur…
Sinocare Inc has a debt-to-equity ratio of 0.31, indicating a relatively conservative capital structure with a strong equity base. The company's current ratio of 1.39 suggests it has sufficient sho…
Universal Vision Biotechnology Co Ltd maintains a debt-to-equity ratio of 0.28, indicating a relatively conservative capital structure. The company's liquidity position is characterized as medium,…
The company maintains a strong liquidity position with a current ratio of 4.3, indicating a robust ability to meet short-term obligations. However, its net cash position is negative after subtracti…
Al Hammadi Holding Company SJSC maintains a relatively strong capital structure, with a current ratio of 2.97, indicating a solid short-term liquidity position. However, the company has no cash and…
The company maintains a strong liquidity position, with a current ratio of 8.77 and a cash and equivalents balance of 6,904.3 million KRW, indicating a robust ability to meet short-term obligations…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥4.26 billion, representing 34.7% of total assets. Its liquidity FPT score indicates a low risk of liquidit…
The company maintains a strong capital structure with a debt-to-equity ratio of 0.12, indicating a conservative leverage position relative to its equity base. Its liquidity position is characterize…
Tomocube's capital structure is characterized by a high liquidity position, with cash and equivalents amounting to KRW 11,449,134,440, which is significantly higher than its total liabilities of KR…
TMS Co Ltd exhibits a highly liquid capital structure, with cash and equivalents amounting to ¥34.18 billion, representing 93.2% of total assets. The company has no long-term debt and a debt-to-equ…
Kangmei Pharmaceutical maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.15, indicating a low reliance on debt financing. The company's liquidity position is c…
The company maintains a strong liquidity position, with a current ratio of 19.91 and cash and equivalents amounting to 527,719,000 TWD, indicating a robust ability to meet short-term obligations. T…
The company's capital structure is characterized by a debt-to-equity ratio of 0.96, indicating a moderate level of leverage. The liquidity position is assessed as medium, with a current ratio of 1.…
Alcon AG maintains a conservative capital structure with a debt-to-equity ratio of 0.24, indicating limited leverage relative to equity. The company's liquidity position is characterized by a curre…
The company's capital structure is highly leveraged, with total liabilities of $30.6 million and total equity of -$186,000, resulting in a debt-to-equity ratio of -120.67. Liquidity is constrained,…
AlzeCure Pharma AB has a current ratio of 2.33, indicating that it holds 2.33 times more current assets than current liabilities, which suggests moderate liquidity. However, the company's operating…
Amgen's capital structure is highly leveraged, with a debt-to-equity ratio of 10.57, indicating a significant reliance on debt financing. The company maintains a liquidity position with a current r…
Alterity Therapeutics has a strong liquidity position, with a current ratio of 12.98 and cash and equivalents amounting to 33,158,640 AUD, indicating a robust ability to meet short-term obligations…
ATX.AX has a strong liquidity position, with a current ratio of 7.91, indicating the company can easily cover its short-term liabilities with its current assets. The company holds significant cash…
AstraZeneca's capital structure is characterized by a debt-to-equity ratio of 0.92, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative approach to leverage. However, the company's liquidity is rated as medium, and its…
Structure and Liquidity Biofrontera has a current ratio of 1.52, indicating that it has $1.52 in current assets for every $1 of current liabilities. The company's liquidity position is assessed as…
BrainCool operates with a strong equity base, as evidenced by a price-to-book ratio of 1.8 and a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidity posit…
Cantargia AB maintains a strong liquidity position, with a current ratio of 9.8 and no long-term debt, indicating a robust balance sheet and minimal leverage risk. The company's liquidity_fpt score…
The company maintains a strong liquidity position with $35.4 million in cash and equivalents, representing 66% of total assets. This liquidity provides a buffer against the $9.96 million in long-te…
MKDWELL Tech Inc has a market capitalization of $109.4 million and a price-to-book ratio of 2.41, indicating that the market values the company at a premium to its book value. The company's liquidi…
Captor Therapeutics maintains a strong liquidity position, with cash and equivalents amounting to 64.89 million PLN, which significantly exceeds its total liabilities of 23.75 million PLN. The comp…
CapsoVision operates with a debt-free capital structure, as evidenced by a zero debt-to-equity ratio and no long-term debt obligations. The company maintains a strong liquidity position with a curr…
Cyprium Mining Limited has a capital structure characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations, and a current ratio of 4.4, suggesting strong short-term liq…
Devyser Diagnostics maintains a strong liquidity position, with cash and equivalents amounting to 201 million SEK, which is significantly higher than its total liabilities of 121.9 million SEK. The…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.